Detailed ANA dynamics under adalimumab therapy show no significant correlation to PASI response and MTX cotreatment: a retrospective study of 98 psoriasis patients.

Hoffmann, J H O; Knoop, C; Enk, A H; Hadaschik, E N

Hoffmann, J H O; Knoop, C; Enk, A H; Hadaschik, E N.

Hoffmann JHO; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
Knoop C; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
Enk AH; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
Hadaschik EN; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.

J Eur Acad Dermatol Venereol ; 33(3): e128-e129, 2019 Mar.

Article en En | MEDLINE | ID: mdl-30394590

Asunto(s)

Adalimumab/uso terapéutico; Antiinflamatorios/uso terapéutico; Anticuerpos Antinucleares/sangre; Psoriasis/tratamiento farmacológico; Adulto; Quimioterapia Combinada; Femenino; Humanos; Inmunosupresores/uso terapéutico; Masculino; Metotrexato/uso terapéutico; Persona de Mediana Edad; Psoriasis/sangre; Estudios Retrospectivos; Índice de Severidad de la Enfermedad

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Antinucleares / Adalimumab / Antiinflamatorios Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google